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Background: The evidence on the effect of acupuncture or counseling for depression is not conclusive yet is
sufficient to warrant further research. Our aim is to conduct a full-scale RCT to determine the clinical and cost
effectiveness of acupuncture and counseling compared to usual care alone. We will explore the experiences and
perspectives of patients and practitioners.
Methods/Design: Randomized controlled trial with three parallel arms: acupuncture plus usual care, counseling
plus usual care, and usual care alone, in conjunction with a nested qualitative study using in-depth interviews with
purposive samples of trial participants.
Participants: Patients aged over 18 years diagnosed with depression or mood disorder by their GP and with a score
of 20 or above on the Beck Depression Inventory (BDI-II).
Randomization: Computer randomization by York Trials Unit to acupuncture, counseling, and usual care alone in
proportions of 2:2:1, respectively, with secure allocation concealment.
Interventions: Patients allocated to acupuncture and counseling groups receive the offer of up to 12 weekly
sessions. Both interventions allow flexibility to address patient variation, yet are constrained within defined
protocols. Acupuncture is based on traditional Chinese medicine and counseling is non-directive within the
humanistic tradition.
Outcome: The PHQ-9 is the primary outcome measure, collected at baseline, 3, 6, 9, and 12 months. Also measured
is BDI-II, SF-36 Bodily pain subscale, and EQ-5D. Texted mood scores are collected weekly over the first 15 weeks.
Health-related resource use is collected over 12 months.
Analysis: The sample size target was for 640 participants, calculated for an effect size of 0.32 on the PHQ-9 when
comparing acupuncture with counseling given 90% power, 5% significance, and 20% loss to follow-up. Analysis of
covariance will be used on an intention-to-treat basis. Thematic analysis will be used for qualitative data. We will
compare incremental cost-effectiveness of the three treatment options at 12 months.
Discussion: Ethical approval was obtained in October 2009. There were six subsequent protocol amendments, the
last of which was approved in January 2012. Recruitment of 755 participants took place over 18 months. Data
collection will be completed by June 2012. No interim analyses have been conducted.
Trial registration: ISRCTN63787732
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Depression will be the second leading cause of disease
burden worldwide by 2020 according to the Global Bur-
den of Disease Study [1]. As of 2000, an estimated 2.6
million cases of depression were reported in England [2],
and it is the third most common reason for primary care
consultations [3]. The economic burden in England is
estimated to exceed £9 billion per annum with approxi-
mately £370 million going to direct costs of treatment
[2]. As many as 50% of people with depression also have
chronic pain [4]. Despite these considerable costs,
current pharmacological and psychological interventions
have limited acceptability and effectiveness. Up to 60%
of patients do not adequately respond to pharmaco-
logical antidepressant treatment [5] and 30% do not ad-
here to medication [3]. Patients have expressed the view
that there is an over-reliance on prescribed antidepres-
sant medications [6] and they are keen to have a range
of possible treatment choices [7]. More recently doubts
have been cast on the effectiveness of newer anti-depres-
sants, particularly in their effectiveness in lower severity
depression [8].
Depression is commonly treated by acupuncturists [9]
although this is rarely provided within NHS mental
health services or primary care [10]. The evidence base
from systematic reviews suggests that there could poten-
tially be benefits from acupuncture, with sufficient evi-
dence to warrant further research [11-13]. Counseling is
a credible and widely used intervention for patients with
depression, with approximately half of the 9,000 GP
practices in England employing a counselor [14].
We have conducted two exploratory studies that are
relevant to this proposal. The first study used mixed
methods to explore the potential role of acupuncture for
depression, using a focus group and a small uncontrolled
outcome study [15]. The focus group of patients who
had experienced depression helped shape our research.
The second study was funded as part of a post-doctoral
fellowship by the NIHR National Co-ordinating Centre
for Research Capacity Development. We first conducted
30 in-depth interviews with patients, acupuncturists, and
general practitioners (GPs). These qualitative data
informed our design of a pilot RCT, including our choice
of patient group, of outcome measures and of compara-
tor interventions. We then conducted a pilot rando-
mized controlled trial where we compared acupuncture
plus usual GP care with counseling plus usual care with
usual GP care alone for patients with depression
(ISRCTN 59267538) [16]. Forty patients were recruited
from two GP practices in York. The main outcome mea-
sures used were the Beck Depression Inventory (BDI-II)
[17] and the Patient Health Questionnaire-9 (PHQ-9)
[18]. When comparing BDI outcomes between acupunc-
ture and counseling and usual care alone at 3, 6, and9 months, we found a growing trend in favor of acupunc-
ture and counseling. Equivalent changes were observed
on the PHQ-9. More importantly, we established the
feasibility of recruitment and identified key features
including the sample size required for a full-scale trial.
For the proposed trial, the primary aim is to evaluate
the clinical and cost effectiveness of acupuncture and
counseling when offered in primary care as an adjunct
to usual GP care. Our secondary aim is to compare acu-
puncture to counseling. Our design with both acupunc-
ture and counseling arms in the one trial is supported by
the recent Cochrane systematic review of acupuncture
for depression that suggested: ‘Future studies may need
to consider the use of comparative designs using medi-
cation or structured psychotherapies (cognitive behav-
ioral therapy, psychotherapy, counseling) or standard
care, due to the ethics of administering this intervention
to this study population’ [11]. We will also be conduct-
ing health economic evaluations to determine the cost-
effectiveness of acupuncture and counseling.
Aims
The primary aim is to determine the clinical and cost ef-
fectiveness of short courses of acupuncture or counsel-
ing for depression when compared to usual GP care.
Important secondary aims are: (a) to determine whether
acupuncture is more effective than counseling or vice
versa; and (b) to compare the experiences of patients,
therapists, and GPs who took part in the trial in order to
identify any relevant issues concerning acceptability, ap-
propriateness, and feasibility in relation to future treat-
ment provision and research.
Methods
Design
A randomized controlled trial will be conducted for
patients with depression who will be allocated to one of
three arms: acupuncture plus usual care, counseling plus
usual care, and usual care alone, in conjunction with a
nested qualitative study with purposive samples of
patients and practitioners participating in the trial.
Inclusion/exclusion criteria
We will recruit patients aged over 18 years who have
been diagnosed with depression or mood disorder and:
(a) have consulted their GP for depression within the
past 5 years; or (b) are currently in receipt of a prescrip-
tion for anti-depressant medication. Participants must
also still be depressed at the time of recruitment, with a
score of 20 or above on the Beck Depression Inventory-
II (the conventional cut-offs used are: 0 to 13 for min-
imal depression; 14 to 19 for mild depression; 20 to 28
for moderate depression; and 29 to 63 for severe depres-
sion) [18]. We will exclude patients who are receiving
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illness, hemophilia, hepatitis, HIV, are pregnant, or who
have a confounding psychiatric condition (bipolar dis-
order, postpartum depression, adjustment disorder,
psychosis, or personality disorder). Patients who have
suffered a close personal bereavement or have given
birth during the previous 12 months will not be eligible
to take part. Because of the specific demands of this
study in terms of the need to fully comprehend detailed
information, to complete questionnaires, to understand
and converse readily with English speaking acupunctur-
ists and counselors, and to permit physical contact, we
intend to exclude patients who have a significant learn-
ing disability, who are unable to converse in English, or
who have dementia.
Randomization
Consenting patients will be allocated remotely by the
York Trials Unit, with the allocation code concealed
from the recruiting researcher, to the three groups in the
proportions of 2:2:1 to acupuncture, counseling, and
usual care alone, respectively.
Outcome measures
The primary clinical outcome is the PHQ-9 [19] at
3 months, as an impact at this time-point is important
to patients, and the primary economic outcome is at
12 months. An evaluation of whether there is an overall
clinical benefit to patients over 12 months is also of con-
siderable importance, and this will be evaluated in terms
of PHQ-9 scores in the first secondary analysis of clin-
ical outcomes. We will use the correlation between the
PHQ-9 and BDI-II at baseline and 12 months to deter-
mine equivalent BDI-II scores at subsequent time points,
in the context that a three-point difference between
groups on the BDI-II is considered clinically significant
[6]. As an additional measure we will use the SF-36 Bod-
ily pain subscale [20]. All patients who agree to be con-
tacted by text messaging will be asked for a single mood
score (from 1 to 9) once a week for the first 15 weeks, in
order to plot the trajectory of change over time, and they
will be reimbursed. As a utility measure, the EQ-5D will
be also be used [21]. Data will be collected at baseline, 3,
6, 9, and 12 months. At baseline we will collect demo-
graphic data as well as prior preferences and expecta-
tions of patients. For both acupuncture and counseling
groups, we will measure the patient’s perception of the
practitioners’ empathy using the Consultational and Re-
lational Empathy (CARE) measure at 3 months, which
we have tested with acupuncture patients [22]. Thera-
pists will record in logbooks the number and length of
times of sessions, the treatment provided, and any ad-
verse events. At 3, 6, 9, and 12 months we will collect
data on the impact of depression on work and normalactivities. We will collect data on NHS resource use and
patients’ private costs, to include additional contacts
with acupuncturists and counselors, and over-the-
counter medication. At 3 months, we will randomize the
overall group into two and send to one group a text
message timed to arrive the day before the question-
naire, reminding the recipients that the questionnaire
will arrive and asking that they return them promptly.
At 6 months the participants will be randomized into
two groups, one will receive the text message before re-
ceiving the questionnaire and the other within the week
following receipt of the questionnaire. At 9 months we
will randomize the group into two and one group will be
sent a text message reminder within the week following
the arrival of the questionnaire. If a text message either
before or after proves to enhance the response rate or
time to response, we will send reminder texts to all
patients to maximize response at the 12-month follow-
up. A £5 note or voucher will be enclosed with the final
questionnaire, as reimbursement is known to enhance
response rates [23].
Using in-depth interviews, qualitative data will be collected
from a purposive sample of patients to gain understanding
of their perceptions and experiences of acupuncture, coun-
seling, and usual GP care using interview schedules with
topic guides. We also explore patients’ preferences, beliefs,
and understanding of their depression, and the impact of
these factors might have on their experience of treatment
and subsequent outcome.
After patient recruitment has been completed, we will
explore the experiences of acupuncturists, counselors,
and GPs who took part in the trial. This will involve
conducting a series of in-depth interviews and focus
groups with individuals drawn from these three profes-
sional groups. These nested qualitative studies will aim
to provide insights that may enhance standards of prac-
tice in relation to the treatment of depression, guide the
development of future randomized controlled trials in-
volving patients with depression, and identify implica-
tions for health policy.
Interventions
Patients allocated to the acupuncture and counseling
groups will receive the offer of 12 sessions on a weekly
basis. The participating acupuncturists will be members
of the British Acupuncture Council who have been
qualified for at least 3 years. The acupuncture treat-
ments will be performed according to a treatment proto-
col already developed for this purpose [24] and tested in
our pilot. This will allow for each patient having a custo-
mized treatment within a standardized theory-driven
framework. Counseling will be provided by members of
the British Association of Counseling and Psychotherapy
using primarily a non-directive approach [25]. A
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will set the parameters for the counseling. Counselors
will use empathy and advanced listening skills to help
clients express feelings, clarify thoughts, and reframe dif-
ficulties, but they will not give advice or set homework.
Variations in treatment of patients by counselors and
acupuncturists will be reported in order to better inter-
pret findings and assess generalizability. Usual GP care
will continue to be available to all patients according to
need, and will be monitored and reported across all
three groups for comparative purposes, and this to in-
clude acupuncture and counseling received, whether
allocated within the trial or not.
Sample size
We will test for an effect size of 0.32 on the PHQ-9
when comparing acupuncture and counseling (1:1) with
90% power and 5% significance, which will require 204
per group. We will test for an effect size of 0.39 when
comparing either acupuncture or counseling to usual
care alone (2:1), with the usual care group being half the
size of the acupuncture and counseling groups, for
which we will need 103 patients in the usual care group.
Allowing for 20% attrition, and randomizing in the pro-
portions 2:2:1 for acupuncture, counseling, and usual
care, respectively, the total sample size required is 640
(that is, groups of 256, 256, and 128, respectively).
One hundred purposively selected patients will be
invited to participate in-depth interviews using a topic
guide, the number to be decided when saturation has
been reached. Forty percent of them (that is, 40 partici-
pants) will be drawn from the group allocated to acu-
puncture, another 40% from those allocated to
counseling, and 20% (that is, 20 participants) will be
from those allocated to usual care alone. In order to cap-
ture and map the diversity, a sampling frame will be
used with sampling criteria based on sex and baseline
scores. In addition, up to 65 therapists/GPs will be
recruited to take part in a qualitative sub-study, which
will explore their experiences of delivering the trial inter-
vention to patients with depression.
Recruitment
Using GP databases for identification and screening, and
based on our finding from our pilot where we recruited
40 patients from GP databases with a combined list of
21,500, we estimate that we will recruit 0.19% of patients
from GP lists. To recruit 640 patients, we estimate a total
primary care list size of approximately 337,000 patients is
required, equivalent to 22 GP practices with an average list
of 15,000 patients each. We have planned an 18-month re-
cruitment period. We will work closely with the Primary
Care Networks to recruit GP practices, ensuring they are
located nearby clusters of suitable therpaists.Acupuncturists, counselors, and GPs who agree to sup-
port the trial will be invited to take part in a qualitative
sub-study after patient recruitment has ended. Each will
receive a participant information sheet and consent forms,
which will be different from those sent to patients.
Analysis
We will compare three clinical outcomes: (1) acupunc-
ture plus usual care versus usual care alone; (2) counsel-
ing plus usual care versus usual care alone; and (3)
acupuncture plus usual care versus counseling plus usual
care.
A pre-specified statistics analysis plan will be used.
Analysis will be on an intention-to-treat basis. We will
use analysis of covariance at 3 months and the ‘area
under the curve’ method at 12 months to assess whether
clinical differences, if any, are significant. In a secondary
analysis, when comparing acupuncture with counseling
((3) above), and to better understand the treatment ef-
fect, we will control for treatment time (number and
length of sessions) and empathy (patient’s score of their
practitioner’s empathy) by including them as covariates
in the analysis. Methods to deal with potentially missing
data will be addressed in detail in the analysis plan. The
proportion of missing data will be summarized at each
time point by allocated treatment, and known reasons
for missing data will be summarized. Multiple imput-
ation based on the standard best-subset regression
method will be used for missing data. We will also esti-
mate whether prior expectations or preferences are ef-
fect modifiers [26].
We will explore practitioner effects by putting a group
of acupuncture patients and a matching number of con-
trols in the same cluster and use a single summary stat-
istic, difference between acupuncture and control
means, for that cluster. We will then estimate the mean
difference across clusters using the t method for the
confidence interval and to test the null hypothesis that
the mean difference is zero. This will deal with the prob-
lem that between cluster variability is expected to be
present for acupuncture patients but not for controls. It
will provide an estimate of the variation between practi-
tioners in treatment effect as well as an estimate of the
treatment effect which allows for practitioner variation.
For the qualitative data, we will audiotape the inter-
views (with the permission of participants) and subse-
quently transcribe verbatim. Qualitative data will be
coded and analyzed thematically within the framework
of illness narratives [27,28] and thematic analysis [29].
This will assist in the interpretation of the quantitative
data from the trial, and provide a better understanding
about who is likely to be attracted to and/or benefit from
prescribed medication, from acupuncture, and from
counseling.
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Figure 1 Recruitment of participants into the ACUDep trial (Acupuncture, Counseling and Usual GP Care for Depression). Total number
of participants recruited = 755.
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with therapists and GPs will be conducted jointly by two
members of the research team to identify emerging
themes and issues, in particular those which would merit
further exploration in the focus groups. These emerging
findings will be reviewed and developed by the full re-
search team (where appropriate drawing on learning
from the main trial) and will be used to shape the topic
guides for the focus groups. Once the focus group phase
has been completed, the transcripts from all the inter-
views and focus groups will be analyzed thematically.
The main areas of inquiry covered in the interview sche-
dules/topic guides will initially be used as a framework
for analyzing the data across all three groups of profes-
sionals contributing to the study. However, within each
main area an ‘inductive’ process will be used to identify
emergent themes and issues [29], and to explore shared
experiences or points of difference between the three
professional groups. As this study is intended to inform
future treatment of patients with depression, the analysis
will also seek to draw out findings which might informthe practice of acupuncturists and counselors, and wider
service delivery for patients with depression. During the
analysis, regular meetings will be held by the research
team to check and shape the themes and to ensure that
any insights gained from the main trial data are incorpo-
rated into this sub-study. Findings derived from inter-
views and focus groups with participating patients,
acupuncturists, counselors, and GPs will then be used
collectively to develop recommendations for future re-
search, policy, and practice in relation to the treatment
of depression.
The economic analysis will consist of a within trial ana-
lysis and an extrapolation of trial outcomes to longer-term
time horizons incorporating other relevant evidence. For
the within trial analysis we will compare the three treat-
ment options based on the NHS costs and effectiveness as
measured by the EQ-5D [21] over the trial follow-up
period. Decision analytic modeling will be used to extend
the trial analysis to the life-time of the patient and include
other relevant information. The incremental cost-
effectiveness ratio will be calculated from the estimation
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analysis will be conducted to allow for a full representation
of parameter uncertainty [30].
Discussion
An initial version of this protocol was approved by York
NHS Research Ethics Committee (Ref no: 09/H1311/75)
on 1 October 2009. A series of six protocol amendments
were subsequently approved, the final one on 4 January
2012. In total, 755 patients have been recruited to the
trial over an 18-month period between November 2009
and April 2011, see Figure 1. The last of the 100 patients
will be recruited to the qualitative sub-study by June
2012. Data collection will be completed by the end of
June 2012. Data entry will be completed by the end of
August. No interim analyses have been conducted. Ana-
lysis of clinical and health economic data will start in
September and is expected to be complete by the end of
2012, followed by submission of primary results to a
peer-reviewed journal in 2013.
Trial status
Closed as of June 2012.
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